A novel human mast cell activation test for peanut allergy - 04/08/18
Doi : 10.1016/j.jaci.2018.03.011
Alexandra F. Santos, MD, PhD a, b, c 
, Natália Couto-Francisco, MSc b, c, Natalia Bécares, PhD b, c, Matthew Kwok, BSc b, c, Henry T. Bahnson, MPH d, Gideon Lack, MBBS, FRCPCH a, b, c
, Natália Couto-Francisco, MSc b, c, Natalia Bécares, PhD b, c, Matthew Kwok, BSc b, c, Henry T. Bahnson, MPH d, Gideon Lack, MBBS, FRCPCH a, b, c a Department of Pediatric Allergy, School of Life Course Sciences, King's College London & Guy's and St Thomas' Hospital NHS Foundation Trust, London, United Kingdom
b Peter Gorer Department of Immunobiology, School of Immunology & Microbial Sciences, King's College London, London, United Kingdom
c MRC & Asthma UK Centre in Allergic Mechanisms of Asthma, London, United Kingdom
d Immune Tolerance Network, Benaroya Research Institute, Seattle, Wash
| Supported by the Medical Research Council (MRC Clinician Scientist Fellowship MR/M008517/1 and MRC Centenary Early Career Award awarded to A.F.S) and the Department of Health via the National Institute for Health Research (NIHR) comprehensive Biomedical Research Centre award to Guy's & St Thomas' NHS Foundation Trust in partnership with King's College London and King's College Hospital NHS Foundation Trust. H.T.B. received support (salary) from the National Institute of Allergy and Infectious Diseases/National Institutes of Health through UM1AI109565 for the statistical analyses and manuscript development. |
|
| Disclosure of potential conflict of interest: A. F. Santos and her institution received grants from the Medical Research Council (MRC; fellowship no. MR/M008517/1); her institution received a grant from the National Institute for Health Research (NIHR) and Immune Tolerance Network/National Institute of Allergy and Infectious Diseases (NIAID; grants ITN032AD and ITN049AD) and from Asthma UK; received other institutional support from MRC & Asthma UK Centre for the Mechanisms of Asthma and the UK Department of Health through the NIHR; she is employed by King's College London; she received lecture fees from Thermo Scientific, Nutricia, and InfoMed; and she received travel fees from the European Academy of Allergy and Clinical Immunology, British Society for Allergy & Clinical Immunology, Academy of Medical Sciences, Portuguese Society of Allergy and Clinical Immunology, Spanish Society of Allergy and Clinical Immunology, French Meeting of Molecular Allergology, Swiss Society of Allergy and Clinical Immunology, Dutch Symposium of Paediatric Allergology, French Society of Immunology, and GAPIC (IMM, Lisbon). H. T. Bahnson's institution received a grant from Benaroya Research Institute and ITN (UM1AI109565) and received consultancy fees from King's College London through a contract with the UK Food Standards Agency (FSA) and iFAAM. G. Lack's institution received grants from the NIAID/NIH (grants NO1-AI-15416 and UM1AI109565) and FSA and other institutional contributions from Food Allergy Research & Education (FARE), the MRC & Asthma UK Centre, the UK Department of Health through the NIHR, the National Peanut Board (NPB), and Osem; he holds board membership, consultancy fees, and stock options from DBV Technologies. The rest of the authors declare that they have no relevant conflicts of interest. |
© 2018
The Authors. Publié par Elsevier Masson SAS. Tous droits réservés.
Vol 142 - N° 2
P. 689 - août 2018 Retour au numéro
Article précédent
- Severity of allergic rhinitis assessed by using urine metabolomic profiling: Proof of concept
- Darryl J. Adamko, Mona M. Khamis, Lisa M. Steacy, Shana Regush, Rhonda Bryce, Anne K. Ellis
- Dexamethasone induces ?3-derived immunoresolvents driving resolution of allergic airway inflammation
- Katerina Pyrillou, Aikaterini-Dimitra Chairakaki, Constantin Tamvakopoulos, Evangelos Andreakos
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?